Inositol nicotinate

CAS : 6556-11-2

Ref. 3D-MI33322

Informations sur le produit

• Nom: Inositol nicotinate
• Synonymes: Inositol niacinatemyo-Inositol hexanicotinate, 3-Pyridinecarboxylic acid, 1,2,3,4,5,6-cyclohexanehexayl ester, Cyclohexane-1,2,3,4,5,6-Hexayl Hexapyridine-3-Carboxylate, Dilcit, Dilexpal, Esantene, Hamovannid, Hexanicit, Hexanicotinoyl inositol, Hexanicotol, Hexopal, Inositol Hexanicotinate, Inositol Nicotinate, Inositol hexaniacinate, Inositol, hexanicotinate, myo-, Linodil, Meso-inositol hexanicotinate, Mesonex, Mesotal, Myo-Inositol Hexanicotinate, Nicotinic acid, hexaester with myo-inositol, Palohex, myo-Inositol, hexa-3-pyridinecarboxylate

Description

Inositol nicotinate is a combination of two substances, inositol and nicotinate. It is used to reduce the risk of heart disease by lowering low-density lipoprotein-cholesterol (LDL) levels. Inositol nicotinate has been shown to increase the surface area of mitochondria, which may be due to its ability to inhibit the release of fatty acids from fat cells. Inositol nicotinate also increases magnesium levels in cells and induces mitochondrial functions. This drug has been tested in cell culture for its effects on skin cells and found that it can reduce the amount of x-linked adrenoleukodystrophy protein (XALD), a substance that accumulates in patients with X-linked adrenoleukodystrophy, an inherited disorder that causes progressive damage to the nervous system. The drugs also have been shown to have beneficial effects on cholesterol metabolism, reducing LDL cholesterol levels, as well as inhibiting platelet aggregation.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 810.72 g/mol
• Formule: C₄₂H₃₀N₆O₁₂
• Degré de pureté: Min. 95%
• Couleur/Forme: White Powder